Schlosser N, Espino-Martínez J, Kloss F, Meyer F, Bardl B, Rosenbaum MA, Regestein L (2021) Host nutrition-based approach for biotechnological production of the antifungal cyclic lipopeptide jagaricin. J Biotechnol 336, 1-9.
Stein J, Schlosser N, Bardl B, Peschel G, Meyer F, Kloss F, Rosenbaum MA, Regestein L (2021) Scalable downstream method for the cyclic lipopetidejagaricin Eng. Life Sci. ,
Roman D, Raguž L, Keiff F, Meyer F, Barthels F, Schirmeister T, Kloss F, Beemelmanns C (2020) Modular solid-phase synthesis of antiprotozoal barnesin derivatives. Org Lett 22(10), 3744-3748.
Sester A, Stüer-Patowsky K, Hiller W, Kloss F, Lütz S, Nett M (2020) Biosynthetic plasticity enables production of fluorinated aurachins. Chembiochem 21(16), 2268-2273.
Dunbar KL, Dell M, Molloy EM, Kloss F, Hertweck C (2019) Reconstitution of iterative thioamidation in closthioamide biosynthesis reveals a novel nonribosomal peptide backbone-tailoring strategy. Angew Chem Int Ed 58(37), 13014-13018.
Fischer D, Gessner G, Fill TP, Barnett R, Tron K, Dornblut K, Kloss F, Stallforth P, Hube B, Heinemann SH, Hertweck C, Scherlach K, Brunke S (2019) Disruption of membrane integrity by the bacteria-derived antifungal jagaricin. Antimicrob Agents Chemother 63(9), e00707-19.
Haensch VG, Neuwirth T, Steinmetzer J, Kloss F, Beckert R, Gräfe S, Kupfer S, Hertweck C (2019) Metal-free aryl cross-coupling directed by traceless linkers. Chem Eur J 25(70), 16068-16073.
Kloss F, Gerbach S (2018) Hürden und Aussichten neuer antimikrobieller Konzepte in Forschung und Entwicklung. [Obstacles and perspectives of new antimicrobial concepts within research and development]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 61(5), 595-605. (Review)
Kloss F, Neuwirth T, Haensch VG, Hertweck C (2018) Metal-free synthesis of pharmaceutically important biaryls by photosplicing. Angew Chem Int Ed 57(44), 14476-14481.
Kloss F, Krchnak V, Krchnakova A, Schieferdecker S, Dreisbach J, Krone V, Möllmann U, Hoelscher M, Miller MJ (2017) In Vivo Dearomatization of the Potent Antituberculosis Agent BTZ043 via Meisenheimer Complex Formation. Angew Chem Int Ed 56(8), 2187-2191.